跳至主要内容
临床试验/ACTRN12605000360617
ACTRN12605000360617终止3 期

A randomised trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node.

Breast Cancer Trials0 个研究点目标入组 1,960 人开始时间: 2005年9月9日最近更新:

试验速览

阶段
3 期
状态
终止
入组人数
1,960

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
Female

入选标准

  • Patients of any age with pathological diagnosis of unifocal breast carcinoma with micrometastases in the sentinel node, who have completed baseline Quality of Life evaluations, and geographically accessible for follow up and who have signed written informed consent.

排除标准

  • Patients with clinical evidence of distant metastases; palpable axillary nodes; Pagets disease without invasive cancer; patients who have received a chemoprevention agent within a year of randomization; patients who are pregnant or lactating; patients with previous or concomitant malignancy.

研究者

相似试验

IBCSG 23-01 Sentinel Node Biopsy Trial | 临床试验